FDA Drug Recalls

Recalls / Class II

Class IID-0628-2016

Product

Invanz (ertapenem) Injection Recon Soln in NS, Packaged as a) 500MG in 50ML Homepumps and b) 1 GM in 100ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.

Affected lot / code info
All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 22-Sep-15, b) 19-Sep-15, 20-Sep-15, 22-Sep-15, 23-Sep-15, 24-Sep-15, 25-Sep-15

Why it was recalled

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Recalling firm

Firm
Sentara Enterprises
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
535 Independence Pkwy Ste 300, N/A, Chesapeake, Virginia 23320-5176

Distribution

Quantity
a) 3 Bags, b) 60 Bags
Distribution pattern
U.S. Including: VA, NC

Timeline

Recall initiated
2015-09-18
FDA classified
2016-01-28
Posted by FDA
2016-02-03
Terminated
2016-06-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0628-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls